Monkeypox in Michigan: Urgent Guide - Essential Facts Inside!

The emergence of monkeypox has prompted significant attention from public health officials, including the Michigan Department of Health and Human Services (MDHHS). Understanding the characteristics of this viral infection is crucial for residents. This guide provides essential insights into monkeypox in Michigan, addressing common questions about its transmission, typical symptoms like rash and fever, and the available prevention strategies, including vaccination. Accurate information empowers individuals and communities to take informed actions.

Image taken from the YouTube channel WZMQ 19 News , from the video titled Monkeypox in Michigan .

Monkeypox, now more commonly referred to as mpox, has emerged as a significant global public health concern, prompting health organizations worldwide to enhance surveillance and public awareness. While not new, the recent widespread outbreaks underscored its potential for community transmission and the critical need for comprehensive understanding and preparedness. This re-emergence necessitates that individuals and communities are well-informed about the virus, its transmission, and effective preventive measures.

Mpox in Michigan: A Local Public Health Priority

Understanding the landscape of mpox in Michigan is particularly relevant for residents and healthcare providers within the state. The Michigan Department of Health and Human Services (MDHHS) has actively monitored the virus, providing guidance and resources to mitigate its spread and impact. While the peak of cases seen during the initial global surge has largely subsided, mpox remains an ongoing public health consideration. Vigilance and informed action are essential to prevent future outbreaks and protect community health. For Michigan residents, knowing the specific context, resources, and prevention strategies available locally is paramount for effective individual and collective response.

Purpose of This Comprehensive Guide

This guide has been developed to serve as an authoritative resource, equipping you with essential facts regarding the current mpox situation. Our primary objective is to provide accurate and up-to-date information that addresses key aspects of the virus, its symptoms, and the current epidemiological picture. More importantly, we aim to empower readers with a clear understanding of practical and effective preventive measures that can safeguard personal health and contribute to broader public health efforts in Michigan. This resource is designed to be a reliable reference point for navigating the complexities of mpox with confidence and knowledge.

While the introduction highlighted the importance of understanding the current public health landscape of Monkeypox in Michigan, to truly grasp the situation and its implications, it's essential to establish a clear foundational understanding of the virus itself. What exactly is Monkeypox, and what are its key characteristics?

What is Monkeypox? An Authoritative Overview

Monkeypox is a viral zoonotic disease, meaning it can spread from animals to humans, and also between people. It is caused by the monkeypox virus, a member of the Orthopoxvirus genus, which also includes the variola virus (the cause of smallpox) and vaccinia virus (used in the smallpox vaccine). Despite its name, monkeys are not the primary natural reservoir; various rodents are believed to harbor the virus in endemic regions.

Historical Context and Emergence

The virus was first identified in laboratory monkeys in Denmark in 1958 during an investigation into a pox-like disease. However, the first documented human case of Monkeypox occurred much later, in 1970, in a 9-month-old boy in the Democratic Republic of Congo (DRC). Since then, Monkeypox has been reported primarily in central and west African countries, where it is considered endemic.

While outbreaks outside Africa were rare, a notable instance occurred in the United States in 2003, linked to imported animals. The global multi-country outbreak that began in 2022 marked a significant shift, demonstrating wider international spread, primarily through human-to-human transmission in new geographic areas, including Michigan.

Key Characteristics and Classification of the Virus

As an Orthopoxvirus, the monkeypox virus shares certain characteristics with its well-known cousin, smallpox, though Monkeypox is generally less severe. Understanding its classification and characteristics is crucial for recognizing and managing the disease.

Viral Classification

The monkeypox virus belongs to the family Poxviridae, subfamily Chordopoxvirinae, and genus Orthopoxvirus. Within the Orthopoxvirus genus, there are two distinct clades of the monkeypox virus: the West African clade and the Congo Basin (Central African) clade. The West African clade is generally associated with milder disease and fewer deaths, and was the clade responsible for the 2022 global outbreak.

Symptoms and Disease Progression

Symptoms of Monkeypox typically begin with flu-like signs, including fever, headache, muscle aches, backache, and profound exhaustion. A distinguishing feature is lymphadenopathy, or swollen lymph nodes, which helps differentiate it from other diseases like smallpox.

Within one to three days after the onset of fever, a characteristic rash usually develops. This rash often starts on the face before spreading to other parts of the body, including the palms of the hands and soles of the feet. The lesions progress through several stages:

• Macules (flat spots)
• Papules (raised bumps)
• Vesicles (fluid-filled blisters)
• Pustules (pus-filled lesions)
• Scabs (crusts that eventually fall off)

The illness typically lasts for 2 to 4 weeks. While most cases are mild, Monkeypox can lead to severe illness or complications, particularly in young children, pregnant individuals, or those with compromised immune systems.

Modes of Transmission

Human-to-human transmission occurs primarily through close, personal, often skin-to-skin contact with an infected person. This can include:

• Direct contact with the infectious rash, scabs, or body fluids.
• Prolonged face-to-face contact leading to exposure to respiratory secretions.
• Intimate physical contact, such as hugging, kissing, or sexual activity.
• Contact with contaminated objects, such as clothing, bedding, or towels used by an infected person.

Animal-to-human transmission can occur through bites or scratches from infected animals, or through direct contact with an infected animal's blood, body fluids, or lesions. It can also occur through the consumption of inadequately cooked meat from infected animals. Understanding these fundamental aspects of Monkeypox provides a critical foundation for discussing its current impact and response efforts within Michigan.

Having established a foundational understanding of Monkeypox, it's now crucial to examine its specific trajectory and impact within the state of Michigan. While the global outbreak has largely waned, understanding the local response provides valuable insights into public health preparedness.

The Monkeypox Outbreak in Michigan: Current Status and Response

Michigan, like many other states, experienced the effects of the global Monkeypox (Mpox) outbreak, particularly in the summer and fall of 2022. The state quickly mobilized its public health infrastructure to monitor, contain, and respond to the emerging threat, demonstrating a coordinated effort to protect its residents.

Epidemiological Status of Mpox in Michigan

During the peak of the 2022 outbreak, Michigan saw a significant number of cases. The first confirmed case in Michigan was reported in July 2022. By early 2023, the Michigan Department of Health and Human Services (MDHHS) reported a cumulative total of over 300 probable and confirmed Mpox cases across the state. These cases were predominantly concentrated in metropolitan areas, mirroring national trends.

Fortunately, the epidemiological landscape has dramatically shifted since then. Through effective public health interventions and increased public awareness, the number of new Mpox cases in Michigan has significantly declined, reaching consistently low levels. As of late 2023 and early 2024, new case reports are exceedingly rare, indicating that the outbreak is well under control within the state. The current status reflects a minimal burden of disease, though surveillance remains ongoing.

Official Response from the Michigan Department of Health and Human Services (MDHHS)

The Michigan Department of Health and Human Services (MDHHS) played a central role in guiding the state's response to the Mpox outbreak. Their actions were swift and comprehensive, encompassing several key areas:

• Surveillance and Data Reporting: MDHHS promptly established a robust surveillance system to track cases, monitor trends, and identify potential clusters. They provided regular public updates through dedicated web pages and dashboards, ensuring transparency and access to critical information for healthcare providers and the public.
• Public Health Guidance: The department issued frequent alerts and detailed guidance to healthcare providers on diagnosis, testing protocols, treatment options, and infection control measures. For the public, MDHHS disseminated essential information regarding symptom recognition, transmission prevention, and vaccination eligibility.
• Testing and Vaccination Efforts: MDHHS worked to expand testing capacity across the state, ensuring that individuals with suspected symptoms could be rapidly tested. Crucially, they also led the statewide vaccination campaign, making the JYNNEOS vaccine available to eligible populations, particularly those at higher risk of exposure. These efforts were vital in curbing the spread.
• Treatment Access: MDHHS also facilitated access to treatments like TPOXX (tecovirimat) for severe cases or those at high risk of severe disease, collaborating with federal partners to ensure supply.

Collaboration with Local Health Departments

The success of Michigan's Mpox response was heavily reliant on the seamless collaboration between MDHHS and local health departments (LHDs) across the state. This partnership ensured that state-level strategies were effectively implemented at the community level.

• Case Investigation and Contact Tracing: LHDs were on the front lines, conducting thorough case investigations, identifying close contacts of confirmed cases, and providing guidance on isolation and prevention. This localized approach was critical for interrupting transmission chains.
• Community Outreach and Education: Local health departments tailored MDHHS guidance to the specific needs of their communities, conducting targeted outreach efforts to raise awareness, distribute educational materials, and address local concerns.
• Vaccine Distribution and Administration: LHDs were pivotal in the logistical efforts of vaccine distribution and administration, setting up clinics and ensuring equitable access to the JYNNEOS vaccine within their respective jurisdictions.
• Resource Coordination: This collaborative framework allowed for efficient sharing of resources, expertise, and personnel, ensuring that both state and local efforts were coordinated and effective in addressing the evolving challenges of the outbreak.

As the Michigan Department of Health and Human Services (MDHHS) and local health departments continue their robust efforts to monitor and contain the Monkeypox outbreak, individual vigilance remains a crucial layer of defense. Understanding the signs and symptoms of Monkeypox is paramount for early detection, which not only facilitates prompt medical care but also helps limit further transmission. This section provides a comprehensive guide to recognizing Monkeypox symptoms, empowering individuals with the knowledge needed to identify potential infections.

Recognizing Monkeypox Symptoms: What to Look Look For

Understanding the signs of Monkeypox is crucial for early detection and intervention. This section provides a comprehensive guide to recognizing the common symptoms, including the characteristic rash, and offers insights into their progression and duration, empowering individuals to know when to suspect a potential infection.

Common Monkeypox Symptoms

Monkeypox typically presents with a distinct set of symptoms that can range from mild to severe. The initial phase often resembles the flu, followed by the appearance of a characteristic rash.

Initial Symptoms (Prodromal Phase)

The first signs of Monkeypox usually appear within 5 to 21 days after exposure, though typically 6 to 13 days. These initial symptoms often include:

• Fever: Often the first symptom, ranging from mild to high.
• Headache: Can be severe.
• Muscle aches (myalgia) and backache: Generalized body pain is common.
• Swollen lymph nodes (lymphadenopathy): This is a key distinguishing feature of Monkeypox compared to smallpox. Lymph nodes in the neck, armpits, or groin may become noticeably swollen and tender, often occurring before the rash appears.
• Chills: Shivering sensations accompanying the fever.
• Exhaustion: A general feeling of being unwell and very tired.

The Distinctive Monkeypox Rash

The hallmark symptom of Monkeypox is the development of a distinctive rash. This rash typically appears 1 to 3 days after the onset of fever and other prodromal symptoms, though in some cases, the rash may be the first or even the only symptom. The rash evolves through several stages:

• Macules: Flat, red lesions.
• Papules: Raised bumps.
• Vesicles: Fluid-filled blisters.
• Pustules: Pus-filled lesions.
• Scabs: The lesions eventually crust over and fall off.

The rash can appear anywhere on the body but often starts on the face, palms of the hands, and soles of the feet. It can also affect the mouth, genitals, and anus. The lesions are often deep-seated and can be painful, itchy, or both. It's important to note that the lesions typically develop at the same stage across all affected areas of the body, unlike some other rashes.

Progression and Duration of Symptoms

The progression of Monkeypox symptoms follows a general pattern, with the illness typically lasting for 2 to 4 weeks.

1. Incubation Period: 5 to 21 days (average 6-13 days) from exposure to symptom onset.
2. Prodromal Phase: Lasts for 1 to 5 days, characterized by flu-like symptoms, including fever and often swollen lymph nodes.
3. Eruptive Phase (Rash): The rash appears 1 to 3 days after the fever and progresses through the stages described above (macules, papules, vesicles, pustules, scabs). This phase can last for several weeks.
4. Healing: The scabs eventually fall off, revealing new skin underneath. An individual is considered infectious from the onset of symptoms until all scabs have fallen off and a new layer of skin has formed.

It's crucial to understand that not everyone will experience all symptoms, and the severity can vary widely. Some individuals, particularly those with milder cases, may only develop a few lesions or experience very mild flu-like symptoms without the characteristic rash.

When to Suspect Monkeypox Infection

Given the varying presentation of symptoms, knowing when to consider a Monkeypox infection is vital. You should suspect Monkeypox and seek medical evaluation if:

• You develop a new, unexplained rash, especially one that fits the description of Monkeypox lesions (deep-seated, firm, often painful, and progressing through stages).
• You experience fever, headache, muscle aches, or swollen lymph nodes, especially if followed by a rash.
• You have had close, prolonged, or intimate contact (including sexual contact) with someone who has confirmed or suspected Monkeypox.
• You have traveled to an area where Monkeypox cases have been reported, or have had contact with individuals from such areas, and subsequently develop symptoms.

If you suspect you may have Monkeypox, it is important to isolate yourself to prevent potential spread and contact a healthcare provider immediately. Do not go directly to an emergency room unless your symptoms are severe, as this can increase the risk of transmission in healthcare settings. Instead, call your doctor's office or local health department for guidance on testing and care. Early diagnosis and appropriate management are key to recovery and limiting community spread.

Recognizing Monkeypox symptoms, as we've discussed, is a critical first step in addressing a potential infection. However, to truly protect ourselves and our communities, it's equally vital to grasp how this virus moves from one person to another. Understanding its transmission pathways empowers us to implement effective prevention strategies.

Understanding Monkeypox Transmission: How the Virus Spreads

Monkeypox transmission primarily occurs through close, sustained contact, making it distinct from highly airborne viruses. While not as easily transmissible as some respiratory viruses, vigilance and understanding its modes of spread are essential for containment.

Direct Contact with Infectious Materials

The most common and significant mode of Monkeypox transmission involves direct physical contact with an infected individual or their body fluids. This includes:

• Skin-to-Skin Contact: Close, prolonged skin-to-skin contact is the primary driver of transmission. This can occur during intimate physical contact, including sexual activity, but also through cuddling, hugging, or prolonged holding. The risk is highest when one person has an active rash or lesions.
• Contact with Rash, Scabs, or Body Fluids: The virus is highly concentrated in the characteristic rash lesions, scabs, and any associated body fluids (like pus or blister fluid). Touching these infectious materials directly, even without intimate contact, can lead to transmission. This emphasizes the importance of avoiding direct contact with an infected person's skin lesions.

Transmission via Respiratory Secretions

While less common than direct skin contact, Monkeypox can also spread through respiratory secretions. This typically requires:

• Prolonged Face-to-Face Contact: Transmission through respiratory droplets, such as those produced during coughing or sneezing, generally necessitates extended periods of close, face-to-face interaction. This is because Monkeypox droplets do not typically travel far or linger in the air for long periods, unlike aerosols from some other respiratory viruses. Brief, casual encounters are generally considered low risk for this type of transmission.

Indirect Contact with Contaminated Materials (Fomites)

The Monkeypox virus can survive on surfaces and objects, leading to indirect transmission. This occurs when a person touches an object or surface that has been contaminated with the virus from an infected person's rash, scabs, or body fluids, and then touches their own eyes, nose, or mouth.

• Contaminated Items: This includes shared items like bedding, towels, clothing, and even eating utensils that have been used by an infected person. While less efficient than direct contact, this route underscores the importance of proper hygiene and avoiding shared personal items when someone is infected. The virus's ability to survive on porous materials like fabric for a period, though less than on hard surfaces, still poses a risk if not properly cleaned or laundered.

Understanding the pathways of Monkeypox transmission, as we've explored, provides the essential foundation for building effective defenses against its spread. Armed with this knowledge, we can now focus on the practical, proactive measures that are critical in limiting the virus's reach within communities and protecting individual health.

Prevention Strategies: Limiting the Spread of Monkeypox

Prevention is key to controlling the Monkeypox outbreak. This section outlines practical and effective strategies to limit the virus's spread, including essential hygiene practices, guidelines for isolating infected individuals, and crucial advice on cleaning and disinfecting environments to protect yourself and your community.

Minimizing Direct Contact and Practicing Hygiene

The most direct way to prevent Monkeypox transmission is to avoid close, sustained contact with individuals who have a Monkeypox rash or symptoms. This fundamental principle underpins several key prevention methods.

Avoiding Close Contact

One of the primary prevention methods involves avoiding direct contact with the rash, scabs, or body fluids of a person with Monkeypox. This includes intimate physical contact, but also extends to touching objects or materials that have been in contact with an infected person.

Such items include:

• Bedding
• Towels
• Clothing
• Eating utensils

It's also prudent to avoid contact with infected animals, particularly rodents and primates in regions where the virus is endemic, as they can also transmit the virus to humans.

Practicing Excellent Hand Hygiene

Regular and thorough hand hygiene is a simple yet powerful barrier against many infections, including Monkeypox. Frequent handwashing with soap and water for at least 20 seconds is highly effective. If soap and water are not readily available, an alcohol-based hand sanitizer containing at least 60% alcohol should be used. This is especially important after coming into contact with anyone who is sick, after touching potentially contaminated surfaces, or before eating.

Isolation for Infected Individuals

To prevent further transmission, strict adherence to isolation guidelines for infected individuals is paramount. Isolation helps to contain the virus within a defined space, preventing its spread to others in the household or community.

Individuals confirmed or suspected to have Monkeypox should:

• Stay home: Avoid public spaces, gatherings, and public transportation.
• Limit contact: Minimize interaction with household members, especially those who are immunocompromised, pregnant, or young children.
• Separate living spaces: If possible, infected individuals should use a separate bedroom and bathroom from others in the household.
• Isolate until fully recovered: Isolation should continue until all lesions have healed, the scabs have fallen off, and a fresh layer of healthy skin has formed underneath. This typically takes two to four weeks.

Healthcare providers will offer specific guidance on the duration and specifics of isolation based on individual circumstances and the progression of the illness.

Cleaning and Disinfecting Environments

The Monkeypox virus can survive on surfaces, making environmental cleaning and disinfection a crucial component of prevention. Regular and thorough cleaning of potentially contaminated environments can significantly reduce the risk of indirect transmission.

What to Clean and How

• High-touch surfaces: Regularly clean and disinfect frequently touched surfaces in shared living spaces, such as doorknobs, light switches, remote controls, phones, and countertops.
• Laundry: Clothing, bedding, and towels used by an infected person should be handled with care. Wash these items separately, preferably using a washing machine with hot water and detergent. If machine washing isn't possible, soak items in a bleach solution before washing. Avoid shaking contaminated laundry to prevent aerosolizing particles.
• Personal items: Dishes and utensils used by an infected person should be washed thoroughly with hot water and soap or run through a dishwasher.

Recommended Disinfectants

For effective disinfection, use an EPA-registered disinfectant (products with an EPA registration number on the label) that is effective against enveloped viruses. Common household disinfectants, such as those containing bleach or quaternary ammonium compounds, are generally effective. Always follow the manufacturer's instructions for concentration and contact time, and ensure adequate ventilation during cleaning. When handling potentially contaminated materials, wearing disposable gloves is recommended.

While prevention strategies are crucial for limiting the spread of Monkeypox, medical interventions offer essential tools for managing the virus once exposure or infection has occurred. This section delves into the critical aspects of diagnosis, immunization, and therapeutic options available to residents, ensuring they are informed about the pathways to care.

Medical Management of Monkeypox: Testing, Vaccination, and Treatment

Understanding the medical tools available for Monkeypox management is vital for both individuals and public health. This includes accurate diagnostic testing, effective vaccination strategies, and appropriate treatment options for those who become ill.

Testing for Monkeypox

Accurate diagnosis is the first step in managing Monkeypox. The primary method for diagnosing Monkeypox is PCR (polymerase chain reaction) testing of a lesion sample. This involves swabbing a skin lesion (such as a blister or pustule) and sending the sample to a laboratory for analysis. The Michigan Department of Health and Human Services (MDHHS) plays a central role in guiding testing protocols and ensuring laboratory capacity across the state.

Testing is typically recommended for individuals who present with a rash consistent with Monkeypox, especially if they have a history of recent exposure or relevant travel. Rapid identification through testing helps confirm cases, enabling prompt isolation and contact tracing to prevent further transmission. While most tests are processed in state or commercial labs, the MDHHS Bureau of Laboratories also has the capacity for testing, contributing to Michigan's preparedness.

Monkeypox Vaccination: The Jynneos Vaccine

Vaccination is a critical component of the public health response to Monkeypox. The Jynneos vaccine (also known as MVA-BN or Imvamune) is currently the only vaccine specifically approved in the United States for the prevention of Monkeypox and smallpox. It is a two-dose vaccine administered subcutaneously, with doses given 28 days apart, though a single dose can offer some protection.

In Michigan, the availability and eligibility criteria for the Jynneos vaccine are primarily guided by recommendations from the Centers for Disease Control and Prevention (CDC) and implemented by the MDHHS and local health departments. During the peak of the 2022 outbreak, vaccination efforts prioritized:

• Individuals who had confirmed or probable exposure to someone with Monkeypox.
• People at higher risk of exposure due to specific activities or occupational roles, such as certain laboratory personnel.
• Individuals who were at increased risk for severe disease due to underlying health conditions or weakened immune systems.

Distribution efforts in Michigan have focused on making the vaccine accessible through local health departments and designated clinics, often requiring appointments due to limited supply and specific eligibility requirements. While the immediate threat has subsided, the vaccine remains a key tool for targeted prevention.

Treatment Options for Monkeypox

For individuals diagnosed with Monkeypox, treatment focuses on two main areas: supportive care to manage symptoms and specific antiviral medications for severe cases or those at high risk of complications.

Most people with Monkeypox experience mild to moderate symptoms and recover fully with supportive care. This includes:

• Pain management: Over-the-counter pain relievers like ibuprofen or acetaminophen.
• Fever reduction: Similar medications to manage fever.
• Skin lesion care: Keeping lesions clean and dry, and covering them to prevent spread and secondary infections. Antiseptic solutions or mild soaps can be used.
• Hydration and nutrition: Ensuring adequate fluid intake and maintaining good nutrition.

For more severe cases, or for individuals at higher risk of severe disease (e.g., immunocompromised individuals, young children, pregnant people, or those with lesions in sensitive areas like the eyes or mouth), specific antiviral treatments may be considered. The primary antiviral medication used for Monkeypox is Tecovirimat (TPOXX). While FDA-approved for smallpox, TPOXX is available for Monkeypox under an Expanded Access Investigational New Drug (EA-IND) protocol, also known as compassionate use.

TPOXX works by inhibiting the virus's ability to replicate. Its use is carefully evaluated by healthcare providers based on the severity of the illness and patient-specific risk factors. Access to TPOXX is facilitated through health departments and the CDC, ensuring it reaches those who need it most.

Beyond the medical specifics of testing, vaccination, and treatment for Monkeypox, lies the comprehensive framework of public health that ensures these measures are effectively deployed and managed across Michigan. This coordinated effort is the backbone of the state's response, orchestrated by key agencies working together to protect communities. Understanding this organized response is key to appreciating the robust public health effort dedicated to managing Monkeypox in Michigan. This section highlights the pivotal roles played by various public health authorities, specifically detailing the central coordination by the Michigan Department of Health and Human Services (MDHHS), the crucial localized efforts of local health departments, and how national guidelines from the Centers for Disease Control and Prevention (CDC) underpin Michigan's comprehensive strategy.

The Role of Public Health Authorities in Michigan's Response

Michigan Department of Health and Human Services (MDHHS)

At the heart of Michigan's Monkeypox response is the Michigan Department of Health and Human Services (MDHHS). This agency serves as the central coordinating body for all public health efforts across the state. Their role is multifaceted, encompassing strategic planning, resource allocation, and statewide communication.

MDHHS is responsible for issuing official guidance and protocols to healthcare providers and the public, ensuring a consistent approach to identifying and managing cases. They collect and analyze epidemiological data, tracking Monkeypox case numbers, trends, and demographics to inform policy decisions and resource deployment. Furthermore, MDHHS plays a crucial role in disseminating accurate and timely information, coordinating press briefings, and updating public advisories on Monkeypox in Michigan. They manage the statewide allocation of resources, including vaccination doses and treatment medications, distributing them strategically to local health departments.

Local Health Departments

While MDHHS provides the overarching framework, local health departments are the critical front-line responders, implementing public health strategies directly within communities across Michigan. Their localized presence allows for a highly targeted and effective response to Monkeypox.

Local health departments are instrumental in conducting contact tracing, diligently identifying and monitoring individuals who may have been exposed to the virus. This vital work helps to contain outbreaks and prevent further spread. They also lead community education initiatives, tailoring messages to specific populations and ensuring residents have access to reliable information about symptoms, prevention, testing, and vaccination options. Crucially, local health departments are often the primary points of access for Monkeypox testing and vaccination services, establishing clinics and outreach programs to facilitate accessibility for all eligible individuals in their regions.

Centers for Disease Control and Prevention (CDC)

Michigan's public health strategy against Monkeypox is significantly informed and supported by national guidelines and resources provided by the Centers for Disease Control and Prevention (CDC). The CDC serves as the nation's leading public health agency, offering scientific expertise, epidemiological insights, and technical assistance.

The CDC develops national recommendations for Monkeypox testing procedures, vaccination eligibility criteria, and treatment protocols. Michigan's MDHHS and local health departments actively adopt and adapt these national guidelines, ensuring that the state's response aligns with the latest scientific understanding and best practices. Beyond guidance, the CDC also provides vital resources, including federal funding, technical support for surveillance and laboratory capacity, and direct allocation of critical supplies such as Jynneos vaccination doses and antiviral medications like Tecovirimat (TPOXX) to states. This national-level support is fundamental to bolstering Michigan's capacity to effectively manage and mitigate the impact of Monkeypox.

Video: Monkeypox in Michigan: Urgent Guide - Essential Facts Inside!

Play Video

Staying informed remains the best defense against monkeypox in Michigan. Continue to follow guidance from local health authorities to protect yourself and your community.